Cargando…
Angiotensin II in liver transplantation (AngLT-1): protocol of a randomised, double-blind, placebo-controlled trial
INTRODUCTION: Catecholamine vasopressors such as norepinephrine are the standard drugs used to maintain mean arterial pressure during liver transplantation. At high doses, catecholamines may impair organ perfusion. Angiotensin II is a peptide vasoconstrictor that may improve renal perfusion pressure...
Autores principales: | Bokoch, Michael P, Tran, Amy T, Brinson, Erika L, Marcus, Sivan G, Reddy, Meghana, Sun, Elizabeth, Roll, Garrett R, Pardo, Manuel, Fields, Scott, Adelmann, Dieter, Kothari, Rishi P, Legrand, Matthieu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660907/ https://www.ncbi.nlm.nih.gov/pubmed/37984940 http://dx.doi.org/10.1136/bmjopen-2023-078713 |
Ejemplares similares
-
The Yin and Yang of the Renin–Angiotensin–Aldosterone System in Acute Kidney Injury
por: Legrand, Matthieu, et al.
Publicado: (2021) -
Effect of a continuous perineural levobupivacaine infusion on pain after major lower limb amputation: a randomised double-blind placebo-controlled trial
por: Hunt, William, et al.
Publicado: (2023) -
Assessing the effectiveness of perioperative s-ketamine on new-onset headache after resective epilepsy surgery (ESPAIN-trial): protocol for a randomised, double-blind, placebo-controlled trial
por: Sloekers, Jiske Cornelia Theresa, et al.
Publicado: (2019) -
Effectiveness, cost-effectiveness and safety of gabapentin versus placebo as an adjunct to multimodal pain regimens in surgical patients: protocol of a placebo controlled randomised controlled trial with blinding (GAP study)
por: Baos, Sarah, et al.
Publicado: (2020) -
Can open label placebos improve pain and gluten tolerance via open label placebos in fibromyalgia patients? A study protocol for a randomised clinical trial in an outpatient centre
por: Paschke, Lena, et al.
Publicado: (2023)